Drug Trial Radar · NCT02819635
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Last checked: Nov 19, 2026Latest source record: Jun 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,302
Actual
Start
Sep 26, 2016
Primary completion
Dec 13, 2021
Study completion Dec 13, 2021
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jun 30, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was comprised of three substudies. The objective of Substudy 1 was to characterize the dose-response, efficacy, and safety of upadacitinib compared to placebo in inducing clinical remission to identify the induction dose of upadacitinib for further evaluation in Substudy 2. The objective of Substudy 2 was to evaluate the efficacy and safety of upadacitinib compared to placebo in inducing clinical remission in participants. The objective of Substudy 3 was to evaluate the efficacy and safety of upadacitinib compared to placebo in achieving clinical remission in participants who had a response following induction with upadacitinib.
Conditions
- Ulcerative Colitis (UC)
Interventions
PlaceboDrug
Film-coated tablet for oral administration
UpadacitinibDrug
Film-coated tablet for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Substudy 1: Percentage Of Participants Who Achieved Clinical Remission Per Adapted Mayo Score at Week 8Time frame: At Week 8
- Substudy 2: Percentage Of Participants Who Achieved Clinical Remission Per Adapted Mayo Score at Week 8Time frame: At Week 8
- Substudy 3: Percentage Of Participants Who Achieved Clinical Remission Per Adapted Mayo Score at Week 52Time frame: At Week 52
Locations
496 sites in 46 countries. Site status is shown where the registry gives one.
Birmingham Gastroenterology Associates P.C /ID# 151276
Birmingham, Alabama
East View Medical Research, LLC /ID# 171183
Mobile, Alabama
CB Flock Research Corporation /ID# 165980
Mobile, Alabama
Delsol Research Management, Ll /Id# 170131
Chandler, Arizona
Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211885
Mesa, Arizona
Arizona Arthritis & Rheumatology Research, PLLC /ID# 169822
Sun City, Arizona
Adobe Clinical Research LLC /ID# 155250
Tucson, Arizona
University of Arizona /ID# 150553
Tucson, Arizona
Citrus Valley Gastroenterology /ID# 151914
Covina, California
Newport Huntington Medical Group /ID# 217005
Huntington Beach, California
UC San Diego Health System /ID# 155185
La Jolla, California
United Medical Doctors /ID# 207464
Los Alamitos, California
TLC Clinical Research Inc /ID# 216829
Los Angeles, California
Gastrointestinal Biosciences Clinical Trials, LLC /ID# 157080
Los Angeles, California
Facey Medical Foundation /ID# 203133
Mission Hills, California
United Medical Doctors - Murrieta /ID# 151211
Murrieta, California
InSite Digestive Health Care - Oxnard /ID# 163414
Oxnard, California
Inland Empire Clinical Trials, LLC /ID# 216038
Rialto, California
San Diego Clinical Trials /ID# 212120
San Diego, California
Medical Assoc Research Grp /ID# 169148
San Diego, California
Univ of California San Francis /ID# 164581
San Francisco, California
Delta Waves, Inc. /ID# 151721
Colorado Springs, Colorado
South Denver Gastroenterology /ID# 151223
Lone Tree, Colorado
Western States Clinical Res /ID# 158076
Wheat Ridge, Colorado
Western Connecticut Medical Group /ID# 169210
Danbury, Connecticut
Medical Research Center of CT /ID# 150482
Hamden, Connecticut
Gastro Florida /ID# 155245
Clearwater, Florida
Moonshine Research Center, Inc /ID# 152533
Doral, Florida
Universal Axon Clinical Research /ID# 213461
Doral, Florida
Palmetto Research, LLC /ID# 151716
Hialeah, Florida
Nature Coast Clinical Research - Inverness /ID# 154064
Inverness, Florida
Encore Borland-Groover Clinical Research /Id# 170912
Jacksonville, Florida
SIH Research Mumtaz, Inc /ID# 163319
Kissimmee, Florida
Cfagi Llc /Id# 202017
Maitland, Florida
University of Miami /ID# 215441
Miami, Florida
Advanced Pharma /ID# 151719
Miami, Florida
New Horizon Research Center /ID# 152474
Miami, Florida
Crystal Pharmacology Research /ID# 151841
Miami, Florida
Coral Research Clinic /ID# 150444
Miami, Florida
Advanced Research Institute, Inc /ID# 163098
New Port Richey, Florida
Showing 40 of 496 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.